Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
RapidPulse, Inc
The purpose of this prospective, open label clinical trial is to assess the initial safety and performance of the RapidPulseTM Aspiration System as frontline approach for patients with acute ischemic stroke due to large vessel occlusions identified within 24 hours of symptom onset (or last seen normal). The study will enroll up to a maximum of 50 subjects in 2 centers in Georgia. Subjects will undergo mechanical thrombectomy procedure and will have post-operative assessments completed at 24 hours and on Day 5-7 or upon hospital discharge.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 years or older
Clinical diagnosis of acute ischemic stroke with symptom onset (or last seen normal) within 24 hours
Large vessel occlusion (LVO) involving the intracranial internal carotid artery (ICA), middle cerebral artery (MCA) M1 or M2 segments, basilar or vertebral artery
Target occlusion can be accessed by the Medtronic React 71 aspiration catheter
You may not be if
Known or suspected intracranial atherosclerotic disease (ICAD)